Back to the main directory
Press Release
- Press release Biocartis Group NV: Disclosure of transparency notifications by GlobeNewsWire
- Correction: Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of November 30, 2022 by GlobeNewsWire
- Karolinska Developments portföljbolag OssDsign publicerar patientrapport från TOP FUSION-studien i vetenskaplig tidskrift by GlobeNewsWire
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- SYNERGIE : Déclaration mensuelle des droits de vote au 31 décembre 2022 by GlobeNewsWire
- Ilkka Oyj – Acquisition of own shares on 4 January 2023 by GlobeNewsWire
- Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022 by GlobeNewsWire
- CRCAM TOULOUSE 31 : by GlobeNewsWire
- SYNERGIE : Bilan du contrat de liquidité - S2 2022 by GlobeNewsWire
- Middlefield Canadian Income PCC: Net Asset Value(s) by GlobeNewsWire
- Nokia Oyj: Omien osakkeiden takaisinosto 04.01.2023 by GlobeNewsWire
- Wendel: Tadaweb, Wendel Growth’s First Direct Investment in Europe by GlobeNewsWire
- EXEL Industries: number of shares and voting rights as of October 31, 2022 by GlobeNewsWire
- EXEL Industries : nombre total de droits de vote et d’actions au 31 octobre 2022 by GlobeNewsWire
- EXEL Industries : nombre total de droits de vote et d’actions au 30 novembre 2022 by GlobeNewsWire
- EXEL Industries : nombre total de droits de vote et d’actions au 31 décembre 2022 by GlobeNewsWire
- Voltalia atteint avec un an d’avance son objectif de 2,6 gigawatts de capacité en exploitation ou construction by GlobeNewsWire
- Dassault Aviation : Prises de commandes, livraisons et carnet de commandes en nombre d’avions neufs au 31 décembre 2022 by GlobeNewsWire
- ORAPI : RESULTATS BONS DE SOUSCRIPTION D’ACTIONS & LEVEE DE L’OPTION D’ACHAT DES ORA2 by GlobeNewsWire
- Banco Comercial Português, S.A. informs about significant items impacting 4th quarter 2022 financial results of Bank Millennium, S.A. by GlobeNewsWire
- Major Shareholder Announcement by GlobeNewsWire
- Inventiva annonce des changements au développement clinique de lanifibranor notamment la préparation d’une nouvelle étude de Phase III chez les patients atteints de NASH avec une cirrhose compensée by GlobeNewsWire
- Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- GBT’s 3D, Multiplanar IC received a Notice of Allowance in Korea by GlobeNewsWire
- Hearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CES by GlobeNewsWire